Stock events for Health Catalyst, Inc. (HCAT)
Health Catalyst's stock price has declined significantly in the past six months. Recent events impacting the stock include the appointment of Ben Albert as CEO, which was met with a positive market reaction. The CEO of the largest shareholder joined the board in December 2025. Health Catalyst reported its Q3 2025 results, which beat revenue expectations but showed flat year-on-year sales. Adjusted EBITDA exceeded guidance, and full-year 2025 EBITDA guidance was also above analyst estimates. The company reported a solid first quarter for fiscal year 2025, exceeding guidance for both revenue and adjusted EBITDA. Health Catalyst reported a solid second quarter of 2024, with both total revenue and adjusted EBITDA exceeding guidance.
Demand Seasonality affecting Health Catalyst, Inc.’s stock price
While specific detailed information on demand seasonality for Health Catalyst's products and services is not explicitly provided, some insights can be inferred from financial reporting and analyst commentary. The company's revenue guidance for Q4 2025 indicated a projected year-on-year decline in sales, and analysts expect a further decline over the next 12 months, suggesting potential demand headwinds. Historically, Q1 has been noted as a softer quarter compared to the rest of the year in terms of client additions. The company's strategic shift to its Ignite platform has been highlighted as a key driver for strong demand.
Overview of Health Catalyst, Inc.’s business
Health Catalyst, Inc. is a provider of data and analytics technology and services for healthcare organizations, operating within the Healthcare sector, specifically in the Health Care Technology and Healthcare Information Services industry. The company's mission is to leverage data to drive improvements in healthcare. Its offerings are centered around its cloud-based data platform, Health Catalyst Ignite™, which unifies clinical, financial, and operational data. Health Catalyst also provides AI-enabled data and analytics solutions. In addition to its technology, Health Catalyst offers a Professional Services segment, encompassing analytics, implementation, strategic advisory, outsourcing, and improvement services. The company's clients primarily include healthcare providers such as large health systems, academic medical centers, community hospitals, and health insurers.
HCAT’s Geographic footprint
Health Catalyst, Inc. is headquartered in South Jordan, Utah, United States. The company provides its data and analytics technology and services to healthcare organizations in the United States. More than 1,100 organizations worldwide rely on Health Catalyst's offerings, impacting hundreds of millions of patient records.
HCAT Corporate Image Assessment
Health Catalyst is recognized as a leading provider of data and analytics technology and services in the healthcare information services sector. The company emphasizes its commitment to safeguarding customer data and supporting healthcare organizations with reliable technology and services. In July 2025, Health Catalyst launched 10 free AI-integrated data toolkits on the Databricks Marketplace. Health Catalyst has previously been recognized as a "Fortune Best Workplaces in Technology™". Some reports suggest potential challenges to its reputation related to financial performance and market competitiveness.
Ownership
The ownership structure of Health Catalyst, Inc. is heavily concentrated among institutional investors, who hold a substantial majority of the shares. Approximately 77.98% of the company's stock is owned by institutional shareholders. Major institutional owners include First Light Asset Management, LLC, BlackRock, Inc., and The Vanguard Group, Inc. The largest individual shareholder is Mathew Paul Arens, owning 11.03 million shares, representing 15.59% of the company. Other significant individual owners (insiders) include Promod Haque.
